Related Experiment Videos
[Peptic acid disease associated with Helicobacter pylori in children. Report of a case]
S Tovar Calderón1, J Ramírez Mayans, P Casaubón Garcín
1Servicio de Gastroenterología, Instituto Nacional de Pediatría, México, D.F.
Revista De Gastroenterologia De Mexico
|January 1, 1992
Insights
This study shows that amoxicillin and bismuth subsalicylate effectively treated a child with peptic acid disease linked to H. pylori infection. This combination therapy led to significant clinical improvement.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Peptic acid disease in children can be debilitating.
- Helicobacter pylori (H. pylori) is a known pathogen associated with gastrointestinal disorders.
- Accurate diagnosis and effective treatment are crucial for pediatric patients.
Observation:
- A pediatric case of peptic acid disease was investigated.
- The condition was associated with Helicobacter pylori (H. pylori) infection.
- Diagnostic methods included biopsy and antibody testing for H. pylori.
Findings:
- Helicobacter pylori (H. pylori) was identified as the causative agent.
- Clinical improvement was achieved using a specific therapeutic regimen.
- The treatment regimen consisted of amoxicillin and bismuth subsalicylate.
Implications:
- This case highlights the efficacy of amoxicillin and bismuth subsalicylate in treating H. pylori-associated peptic acid disease in children.
- The findings support the use of this combination therapy for similar pediatric cases.
- Further research may explore the broader application of this treatment in pediatric populations.
Abstract:
We studied a child with peptic acid disease which was associated with H. pylori. The identification of H. pylori was done by biopsy and for antibody test. Clinical improvement was observed only with the use of amoxocilin and Bismuth subsalycilate.